Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a canadian first nation

Preventing Chronic Disease

Volumn 8, Issue 1, 2011, Pages

  Riediger, Natalie D ^a   Bruce, Sharon G ^a   Young, T Kue ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; LIPID;

ADOLESCENT; ADULT; AGING; AMERICAN INDIAN; ARTICLE; BLOOD; CANADA; CARDIOVASCULAR DISEASE; ETHNOLOGY; FEMALE; HUMAN; MALE; RISK FACTOR; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; AGING; APOLIPOPROTEINS; CANADA; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; LIPIDS; MALE; RISK FACTORS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 78650814653     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anand SS, Yusef S, Jacobs R, Davis AD, Yi Q, Gerstein H, et al. Risk factors, atherosclerosis, and cardiovascular disease among aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001;358(9288):1147-53.
2. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 2006;259:493-519.
3. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33.
4. Garfagnini A, Devoto G, Rosselli P, Boggiano P, Venturini M. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease. Eur Heart J 1995;16(4):465-70.
5. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 2004;42(12):1355-63.
6. Retnakaran R, Hanley AJ, Connelly PW, Harris SB, Zinman B. Cigarette smoking and cardiovascular risk factors among aboriginal Canadian youths. CMAJ 2005;173(8):885-9.
7. Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele R, Connelly PW, et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract 2002;55(2):165-73.
8. Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohn J, et al. Metabolic syndrome and its components as predictors of incident type 2 dia betes mellitus in an aboriginal community. CMAJ 2009;180(6):617-24.
9. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care 2008;31(9):1837-41.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
11. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008;156:112-9.
12. Wang Z, Rowley K, Wang Z, Piers L, O'Dea K. Anthropometric indices and their relationship with diabetes, hypertension and dyslipidemia in Australian Aboriginal people and Torres Strait Islanders. Eur J Cardiovasc Prev Rehabil 2007;14(2):172-8.
13. Kue Young T, Chateau D, Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in 3 Canadian populations. Am J Hum Biol 2002;14(5):649-58.
14. Gerdes LU, Schmidt EB, Klausen IC, Kristensen SD, Ernst E, Faergeman O, et al. Plasma concentration levels of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in Greenland Inuit (Eskimos). J Intern Med 1992;231:623-5.
15. Pollex RL, Hanley AJ, Zinman B, Harris SB, Hegele RA. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population. Int J Obes (Lond) 2006;30(3):484-91.
16. Wang Z, Hoy WE. Association between diabetes and coronary heart disease in aboriginal people: are women disadvantaged? Med J Aust 2004;180(10):508-11.
17. Magkos F, Mohammed BS, Mittendorfer B. Effect of obesity on the plasma lipoprotein profile in normoglycemic and normolipidemic men and women. Int J Obes (Lond) 2008;32(11):1655-64.
18. El Harchaoui K, Arsenault BJ, Franssen R, Després JP, Hovingh GK, Stroes ES, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 2009;150(2):84-93.
19. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003;52(2):453-62.
20. Howard BV, Pan XR, Harper I, Kuusi T, Taskinen MR. Lack of sex differences in high density lipoproteins in Pima Indians. Studies of obesity, lipase activities, and steroid hormones. Arteriosclerosis 1987;7(3):292-300.
21. Pitsavos C, Panagiotakos DB, Skoumas J, Papadi-mitriou L, Stefanadis C. Risk stratification of the apolipoprotein B, apolipoprotein A1, and apolipoprotein B/A1 ratio on the prevalence of the metabolic syndrome: the ATTICA study. Angiology 2008;59(3):335-41.